Despite the challenges to the general anesthesia drug market precipitated by COVID-19, its market share is projected to hit $2.4 billion by 2025. That’s a robust compound annual growth rate of 3.4%. But how did we get here? Who’s controlling this market? And how do we ride the crest of this wave without wiping out? […]